logo

For the Inventor, By the Inventor

Omaha, NE, United States of America

Creighton University

USPTO Granted Patents = 69

% Expired Patents = 14.5



Trademarks = 14

Forward Citations = 393

Loading Chart...
Loading Chart...

121 inventors (with patents filed for the assignee):

goldMedal Nancy D Hanson (9 out of 9 patents)

silverMedal Zhao Yi Wang (6 out of 6 patents)

bronzeMedal Jennifer A Black (6 out of 9 patents)

4.  Kenneth S Thomson (6 out of 8 patents)

5.  Charles J Filipi (5 out of 9 patents)

6.  Ellen S Moland (5 out of 5 patents)

7.  Sandor Lovas (5 out of 5 patents)

8.  Anton F Ehrhardt (4 out of 4 patents)

9.  Christine C Sanders (4 out of 12 patents)

10.  Alekha Dash (3 out of 4 patents)

11.  Nicholas Palermo (3 out of 4 patents)

12.  Kristen Drescher (3 out of 3 patents)

13.  Robert R Recker (3 out of 9 patents)

14.  Laura Hansen (3 out of 3 patents)

15.  Stacey Morrow (3 out of 3 patents)


Core Competencies:
Quantum Dots
Microbial Resistance
Pain Treatment
Drug Release
CDK2-PROTACs
Nanoparticles
Cancer Therapy
Seizure Therapy
Estrogen Receptors
Antibiotic Detection
Inflammation Treatment
Neuropeptides

69 patents:

1. 12582715 - Cancer radiation therapy with biocompatible quantum dots for simultaneous dose enhancement and counter-metastasis (2026-03-24),
2. 12385102 - Assays and methods for determining microbial resistance (2025-08-12),
3. 12246058 - Methods and compositions for treating pain (2025-03-11),
4. 12146191 - Detection and classification of IMP carbapenemases using real-time polymerase chain reaction assay (2024-11-19),
5. 12122852 - 14-3-3 targeting peptides for cancer treatment (2024-10-22),
6. 11744896 - Compositions, use, and method for CDK2-PROTACs for cancer therapy and hearing loss (2023-09-05),
7. 11708614 - Assays and methods for determining microbial resistance (2023-07-25),
8. 11685766 - 14-3-3 targeting peptides for cancer treatment (2023-06-27),
9. 11608328 - Chemical probes to identify anti-mycobacterial MmpL3 inhibitors (2023-03-21),
10. 11518784 - 14-3-3 targeting peptides for cancer treatment (2022-12-06),
11. 11154619 - Liposomal compositions with light illumination-induced drug release (2021-10-26),
12. 11058655 - Compositions and methods for treatment of inflammation (2021-07-13),
13. 10907217 - High resolution melt-curve analysis to identify the sequence type of (2021-02-02),
14. 10613011 - Diffusion cells and related methods (2020-04-07),
15. 10525027 - Compositions and methods for treatment of inflammation (2020-01-07),
Company Overview
Creighton University, located in Omaha, Nebraska, is a prominent institution engaged in advanced research and development in the field of cancer treatment. The university specializes in innovative technologies such as quantum dots, nanoparticles, and CDK2-PROTACs, focusing on enhancing therapeutic efficacy and addressing challenges in microbial resistance and pain management. Creighton is dedicated to pioneering solutions that improve patient outcomes in cancer therapy and seizure treatment, contributing significantly to the medical and scientific communities.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Creighton University USPTO Patent Assignee Logo
69 Patents

#9 in Omaha, NE

#15 in Nebraska

#5,317 in US

#10,773 in the World

Omaha, NE (US)
Omaha, NE, United States of America

Creighton University

Forward Citations = 393

121 inventors:

goldMedal Nancy D Hanson (9 out of 9 patents)

silverMedal Zhao Yi Wang (6 out of 6 patents)

bronzeMedal Jennifer A Black (6 out of 9 patents)

4.  Kenneth S Thomson (6 out of 8 patents)

5.  Charles J Filipi (5 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Creighton University. Retrieved from https://idiyas.com/company/creighton-university

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…